Xeris Biopharma Holdings Inc. is a leading pharmaceutical company focused on developing innovative, patient-friendly therapies for complex chronic conditions. Their specialized formulations and delivery systems aim to improve treatment outcomes and enhance patient convenience. With a strong track record of successful clinical trials and a robust pipeline, Xeris Biopharma is poised for continued growth and market expansion.
